vs
Side-by-side financial comparison of ALCON INC (ALC) and GSK plc (GSK), based on the latest 10-Q / 10-K filings. Click either name above to swap in a different company.
Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. Alcon is incorporated in the Canton of Fribourg, Switzerland, and its global headquarters are located in Geneva, but its main operational base is in Fort Worth, Texas, United States, where it employs about 4,500 people.
GSK plc is a British multinational pharmaceutical and biotechnology company. It was established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, which was itself a merger of a number of pharmaceutical companies around the Smith, Kline & French firm. It is headquartered in London, England.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history — bar widths are scaled to the larger of the two companies so you can eyeball the size gap and growth trajectory without doing math. Quarters aligned by calendar period (report date) so offset fiscal years line up.
| Q2 25 | $2.6B | — | ||
| Q2 24 | $2.5B | — | ||
| Q2 23 | $2.4B | — | ||
| Q2 22 | $2.2B | — |
| Q2 25 | $176.0M | — | ||
| Q2 24 | $223.0M | — | ||
| Q2 23 | $169.0M | — | ||
| Q2 22 | $148.0M | — |
| Q2 25 | 53.5% | — | ||
| Q2 24 | 55.0% | — | ||
| Q2 23 | 56.3% | — | ||
| Q2 22 | 54.3% | — |
| Q2 25 | 9.5% | — | ||
| Q2 24 | 12.7% | — | ||
| Q2 23 | 11.1% | — | ||
| Q2 22 | 9.0% | — |
| Q2 25 | 6.8% | — | ||
| Q2 24 | 8.9% | — | ||
| Q2 23 | 7.0% | — | ||
| Q2 22 | 6.7% | — |
| Q2 25 | $0.35 | — | ||
| Q2 24 | $0.45 | — | ||
| Q2 23 | $0.34 | — | ||
| Q2 22 | $0.30 | — |
Financial Flow Comparison
Sankey diagram of revenue → gross profit → operating profit → net profit for each company. Charts shown full-width and stacked so both segment hierarchies are readable side-by-side on desktop and mobile.
